×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KROS – keros therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KROS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/27
03:56 pm
kros
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Keros Therapeutics, Inc. - KROS
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Keros Therapeutics, Inc. - KROS
12/27
10:30 am
kros
An Investigation Has Commenced on Behalf of Keros Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your KROS Losses
Low
Report
An Investigation Has Commenced on Behalf of Keros Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your KROS Losses
12/27
10:00 am
kros
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Keros Therapeutics, Inc. (KROS) And Encourages Shareholders to Reach Out
Low
Report
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Keros Therapeutics, Inc. (KROS) And Encourages Shareholders to Reach Out
12/26
03:30 pm
kros
Shareholder Rights Advocates at Levi & Korsinsky Investigate Keros Therapeutics, Inc. (KROS) Regarding Possible Securities Fraud Violations
Low
Report
Shareholder Rights Advocates at Levi & Korsinsky Investigate Keros Therapeutics, Inc. (KROS) Regarding Possible Securities Fraud Violations
12/26
03:00 pm
kros
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Keros Therapeutics, Inc. - KROS
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Keros Therapeutics, Inc. - KROS
12/26
10:45 am
kros
An Investigation Has Commenced on Behalf of Keros Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your KROS Losses
Low
Report
An Investigation Has Commenced on Behalf of Keros Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your KROS Losses
12/26
10:00 am
kros
Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Low
Report
Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
12/26
10:00 am
kros
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Shareholders to Learn More About the Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Shareholders to Learn More About the Investigation
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
04:01 pm
KROS
keros therapeutics, inc. - common stock
MISS
Report
1.1%
keros therapeutics, inc. - common stock
8/7/2024
04:01 pm
KROS
keros therapeutics, inc. - common stock
MISS
Report
-2.2%
keros therapeutics, inc. - common stock
5/8/2024
08:00 am
KROS
keros therapeutics, inc. - common stock
BEAT
Report
-0.6%
keros therapeutics, inc. - common stock
2/28/2024
04:01 pm
KROS
keros therapeutics, inc. - common stock
BEAT
Report
-0.8%
keros therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/12
06:01 am
kros
Form 8-K Keros Therapeutics, Inc. For: Dec 12
High
Report
Form 8-K Keros Therapeutics, Inc. For: Dec 12
12/10
06:01 am
kros
Form 8-K Keros Therapeutics, Inc. For: Dec 09
Medium
Report
Form 8-K Keros Therapeutics, Inc. For: Dec 09
12/3
07:02 am
kros
Form 8-K Keros Therapeutics, Inc. For: Dec 03
High
Report
Form 8-K Keros Therapeutics, Inc. For: Dec 03
11/26
08:03 am
kros
Form 8-K Keros Therapeutics, Inc. For: Nov 26
Low
Report
Form 8-K Keros Therapeutics, Inc. For: Nov 26
11/12
04:16 pm
kros
Form 4 Keros Therapeutics, Inc. For: Nov 08 Filed by: CHYUNG YUNG H.
Low
Report
Form 4 Keros Therapeutics, Inc. For: Nov 08 Filed by: CHYUNG YUNG H.
11/8
04:20 pm
kros
Form 3 Keros Therapeutics, Inc. For: Nov 01 Filed by: CHYUNG YUNG H.
Low
Report
Form 3 Keros Therapeutics, Inc. For: Nov 01 Filed by: CHYUNG YUNG H.
11/6
04:23 pm
kros
Form 10-Q Keros Therapeutics, Inc. For: Sep 30
Low
Report
Form 10-Q Keros Therapeutics, Inc. For: Sep 30
11/6
04:02 pm
kros
Form 8-K Keros Therapeutics, Inc. For: Nov 06
Low
Report
Form 8-K Keros Therapeutics, Inc. For: Nov 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/13
Keros Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
18.3%
4/8 Form 424B4 Keros Therapeutics, Inc. 7.4%
4/20 Form SC 13D Keros Therapeutics, Inc. Filed by: Arkin Moshe 6.5%
4/11 U.S. IPO Weekly Recap: Keros Therapeutics Rises 35% As Biotechs Beat The IPO Shutdown [Seeking Alpha] 5.7%
4/23 Form SC 13D Keros Therapeutics, Inc. Filed by: Pontifax Management 4 G.P. (2015) Ltd. 3.8%
4/8 Form 424B4 Keros Therapeutics, Inc. 7.4%
4/20 Form SC 13D Keros Therapeutics, Inc. Filed by: Arkin Moshe 6.5%
4/11 U.S. IPO Weekly Recap: Keros Therapeutics Rises 35% As Biotechs Beat The IPO Shutdown [Seeking Alpha] 5.7%
4/23 Form SC 13D Keros Therapeutics, Inc. Filed by: Pontifax Management 4 G.P. (2015) Ltd. 3.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: